<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T01:08:21Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11130" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/11130</identifier><datestamp>2026-10-18T21:13:14Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Therapeutic effects of resveratrol and β-carotene on L-arginine-induced acute pancreatitis through oxidative stress and inflammatory pathways in rats</dc:title><dc:creator>Gezer, Arzu</dc:creator><dc:creator>Üstündağ, Hilal</dc:creator><dc:creator>Özkaraca, Mustafa</dc:creator><dc:creator>Sari, Ebru Karadağ</dc:creator><dc:creator>Gür, Cihan</dc:creator><dc:subject>Acute pancreatitis</dc:subject><dc:subject>Apoptosis</dc:subject><dc:subject>L-arginine</dc:subject><dc:subject>Oxidative stress</dc:subject><dc:subject>Resveratrol</dc:subject><dc:subject>İnflammation</dc:subject><dc:subject>β‐carotene</dc:subject><dc:subject>Acute Disease</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Antioxidants</dc:subject><dc:subject>Arginine</dc:subject><dc:subject>beta Carotene</dc:subject><dc:subject>Disease Models, Animal</dc:subject><dc:subject>Inflammation</dc:subject><dc:subject>Male</dc:subject><dc:subject>Pancreas</dc:subject><dc:subject>Pancreatitis</dc:subject><dc:subject>Rats</dc:subject><dc:subject>Rats, Sprague-Dawley</dc:subject><dc:subject>antioxidant</dc:subject><dc:subject>animal</dc:subject><dc:subject>disease model</dc:subject><dc:subject>drug effect</dc:subject><dc:subject>drug therapy</dc:subject><dc:subject>metabolism</dc:subject><dc:subject>pathology</dc:subject><dc:subject>rat</dc:subject><dc:subject>Sprague Dawley rat</dc:subject><dc:description>Acute pancreatitis (AP) is a severe inflammatory condition affecting the pancreas, often leading to systemic inflammation and organ dysfunction. This study evaluated the effects of resveratrol (RES) and β‐carotene (βC) on L-arginine-induced AP in rats. Forty-eight male Sprague Dawley rats were divided into six groups: Control (C), RES (20 mg/kg), βC (50 mg/kg), AP, AP + RES, and AP + βC. The AP model was induced with 250 mg/100 g L-arginine intraperitoneally twice daily with a 1-h interval. The AP group showed significantly elevated oxidative stress (MDA) and reduced GSH levels (p &lt; 0.001). Immunohistochemical (IHC) staining with anti-insulin antibody revealed reduced β + langerhans islet size in the AP group. qPCR analysis indicated significant upregulation of inflammatory genes NF-κB, TNF-α, and IL-1β (p &lt; 0.001), and apoptotic genes Bax and Caspase-3, with downregulation of Bcl-2 (p &lt; 0.001). RES and βC treatments significantly reduced MDA levels and increased GSH levels (p &lt; 0.01 for both) compared to the AP group. The AP + RES and AP + βC groups exhibited preserved β + Langerhans islet size (p &lt; 0.01), suppressed NF-κB, TNF-α, and IL-1β expression, reduced Bax and Caspase-3 levels, and increased Bcl-2 levels (p &lt; 0.01). Histopathological findings supported these results. RES and βC confer significant effects against L-arginine-induced acute pancreatitis by reducing oxidative stress, preserving pancreatic islet integrity, suppressing inflammatory responses, and modulating apoptotic pathways. RES demonstrated a slightly superior efficacy in reducing inflammation and oxidative stress markers, suggesting it may be more effective in treating acute pancreatitis. © The Author(s) 2024.</dc:description><dc:publisher>Nature Research</dc:publisher><dc:date>2024</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/11130</dc:identifier><dc:identifier>https://doi.org/10.1038/s41598-024-83764-y</dc:identifier><dc:identifier>2045-2322</dc:identifier><dc:language>en</dc:language><dc:relation>Scientific Reports</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11130</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>